Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  302 نتائج ل ""COVID-19 Drug Treatment""

فلترة النتائج

Publisher : public library of science
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Effectiveness of Anti-SARS-CoV-2 monoclonal antibodies in real-life: RNAemia and clinical outcomes in high-risk COVID-19 patients.

  • Authors : Marsiglia MD; Department of Health Sciences, Università degli Studi di Milano, Milano, Italy.; Bianchi S

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics ; RNA, Viral*/RNA, Viral*/RNA, Viral*/blood

  • Source: PloS one [PLoS One] 2025 Apr 25; Vol. 20 (4), pp. e0321356. Date of Electronic Publication: 2025 Apr 25 (Print Publication: 2025).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Kyungok-go for fatigue in patients with long COVID: Double-blind, randomized, multicenter, pilot clinical study protocol.

  • Authors : Yoon J; Korean Medicine Data Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea.; Kim S

Subjects: Fatigue*/Fatigue*/Fatigue*/drug therapy ; Fatigue*/Fatigue*/Fatigue*/etiology ; COVID-19*/COVID-19*/COVID-19*/complications

  • Source: PloS one [PLoS One] 2025 Apr 01; Vol. 20 (4), pp. e0319459. Date of Electronic Publication: 2025 Apr 01 (Print Publication: 2025).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Improving patient recruitment to randomised trials can be cost-effective: A case-study of dexamethasone from the RECOVERY trial.

  • Authors : Gkekas A; York Trials Unit, Department of Health Sciences, University of York, York, United Kingdom.; Ronaldson SJ

Subjects: Dexamethasone*/Dexamethasone*/Dexamethasone*/therapeutic use ; Dexamethasone*/Dexamethasone*/Dexamethasone*/economics ; COVID-19 Drug Treatment*

  • Source: PloS one [PLoS One] 2025 Apr 01; Vol. 20 (4), pp. e0314593. Date of Electronic Publication: 2025 Apr 01 (Print Publication: 2025).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Integration of metabolomics and chemometrics with in-silico and in-vitro approaches to unravel SARS-Cov-2 inhibitors from South African plants.

  • Authors : Makoana KM; Department of Biology, School of Science and Technology, Sefako Makgatho Health Science University, Pretoria, South Africa.; Naidoo CM

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/drug effects ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/enzymology ; Metabolomics*/Metabolomics*/Metabolomics*/methods

  • Source: PloS one [PLoS One] 2025 Mar 26; Vol. 20 (3), pp. e0320415. Date of Electronic Publication: 2025 Mar 26 (Print Publication: 2025).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

The effect of antibiotic prescription in non-critically ill hospitalized patients with COVID-19: A Japanese inpatient database study.

  • Authors : Imai H; Department of Infectious Diseases, Graduate School of Medicine, Tohoku University, Sendai, Japan.; Division of Infectious Diseases, Tohoku Medical and Pharmaceutical University Hospital, Miyagi, Japan.

Subjects: COVID-19*/COVID-19*/COVID-19*/mortality ; COVID-19*/COVID-19*/COVID-19*/virology ; COVID-19*/COVID-19*/COVID-19*/complications

  • Source: PloS one [PLoS One] 2025 Mar 25; Vol. 20 (3), pp. e0318803. Date of Electronic Publication: 2025 Mar 25 (Print Publication: 2025).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Effect of Chinese herbal medicine (CHM) as an adjunctive therapy in distinct stages of patients with COVID-19: A systematic review and meta-analysis.

  • Authors : Gu JM; Institute of Clinical Medicine, Beijing University of Chinese Medicine, Beijing, China.; Respiratory Department, China-Japan Friendship Hospital, Beijing, China.

Subjects: Drugs, Chinese Herbal*/Drugs, Chinese Herbal*/Drugs, Chinese Herbal*/therapeutic use ; COVID-19 Drug Treatment*; Humans

  • Source: PloS one [PLoS One] 2025 Feb 13; Vol. 20 (2), pp. e0318892. Date of Electronic Publication: 2025 Feb 13 (Print Publication: 2025).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Treatment with the CCR5 antagonist OB-002 reduces lung pathology, but does not prevent disease in a Syrian hamster model of SARS-CoV-2 infection.

  • Authors : Warner BM; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.; Vendramelli R

Subjects: Lung*/Lung*/Lung*/pathology ; Lung*/Lung*/Lung*/virology ; Lung*/Lung*/Lung*/drug effects

  • Source: PloS one [PLoS One] 2025 Feb 05; Vol. 20 (2), pp. e0316952. Date of Electronic Publication: 2025 Feb 05 (Print Publication: 2025).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Effect of nirmatrelvir/ritonavir (Paxlovid) on hospitalization among adults with COVID-19: An electronic health record-based target trial emulation from N3C.

Subjects: Ritonavir*/Ritonavir*/Ritonavir*/therapeutic use ; Ritonavir*/Ritonavir*/Ritonavir*/administration & dosage ; COVID-19 Drug Treatment*

  • Source: PLoS medicine [PLoS Med] 2025 Jan 17; Vol. 22 (1), pp. e1004493. Date of Electronic Publication: 2025 Jan 17 (Print Publication: 2025).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Data mining of adverse drug event signals with Nirmatrelvir/Ritonavir from FAERS.

  • Authors : Sun J; The Affiliated Changsha Hospital of Xiangya School of Medicine, Central South University, Changsha, China.; The First Hospital of Changsha, Changsha, PR China.

Subjects: Ritonavir*/Ritonavir*/Ritonavir*/adverse effects ; Ritonavir*/Ritonavir*/Ritonavir*/therapeutic use ; Data Mining*

  • Source: PloS one [PLoS One] 2024 Dec 31; Vol. 19 (12), pp. e0316573. Date of Electronic Publication: 2024 Dec 31 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Clinical effects of dexamethasone among patients with sickle cell disease hospitalized with COVID-19: Outcomes from a single academic health system.

  • Authors : Garneau WM; Division of Hospital Medicine, Department of Medicine, Johns Hopkins Hospital, Baltimore, MD, United States of America.; Lankiewicz MJ

Subjects: Dexamethasone*/Dexamethasone*/Dexamethasone*/therapeutic use ; Dexamethasone*/Dexamethasone*/Dexamethasone*/adverse effects ; Anemia, Sickle Cell*/Anemia, Sickle Cell*/Anemia, Sickle Cell*/complications

  • Source: PloS one [PLoS One] 2024 Nov 26; Vol. 19 (11), pp. e0313289. Date of Electronic Publication: 2024 Nov 26 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  302 نتائج ل ""COVID-19 Drug Treatment""